Professional
Added to YB: 2024-02-15
Pitch date: 2024-02-14
TLIS [bullish]
Talis Biomedical Corporation
-65.82%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Company Info
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States.
Market Cap
$5.2M
Pitch Price
$8.31
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.97
P/E
-0.10
EV/Sales
-87.96
Sector
Health Care Equipment and Supplies
Category
special_situation
Talis Biomedical Corporation Faces Challenges Amidst Downsizing and Litigation, Yet Remains Intriguing Investment Opportunity
$TLIS trades 60% below cash after big downsizing to 10 staff. 76% owned by Baker Bros & Einhorn. Liquidation or reverse merger likely but lawsuit over Covid test EUA nondisclosure a risk. Still attractive post 13% rise since SSI pitch at steep discount to cash.
Read full article (1 min)